At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Sorted Descending Type Shares Traded Price Range
Jun 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 6.64
Dec 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 7.98
Jan 2, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.00
Feb 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.69
Nov 3, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.45
Mar 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.06
Sep 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 13.86
Oct 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 15.10
Aug 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 15.61
Jul 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
Jun 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.20
May 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
Mar 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 9.85
Apr 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 11.49
Feb 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.24
Jan 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.34
Oct 2, 2007 dentzer james e Officer Disposition (Non Open Market) 2,500 17.35
Nov 1, 2007 dentzer james e Officer Disposition (Non Open Market) 220 16.17
Dec 3, 2007 dentzer james e Officer Disposition (Non Open Market) 220 15.30
May 30, 2007 dentzer james e Officer Statement of Ownership 0 n/a
Showing 61-80 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy